Baganday, Laga E.
HRN: 27-23-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/02/2025
06/08/2025
IVTT
600mg
Q6
T/c Sepsis? Cap;
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes